Livingston, Scotland – March 16, 2015 – Touch Bionics, a provider of world-leading upper limb prosthetic technologies, announced that new coding issued by the Centers for Medicare and Medicaid Services (CMS) will increase patient access to the company’s prosthetic solutions for partial hands.
CMS recently issued new coding and updated allowables that will pave the way for patients covered by these payers to access i-limb digits technology.
Up until this point, there has been no appropriate base code which can be billed in conjunction with the code relating to articulating digit technology (L6715). But CMS has now issued a new code (L6026) that is specific to partial hand patients.
At the start of 2015, the allowables for all of the appropriate i-limb digits codes were also increased.
The addition of the new base code for partial hand patients, plus the increased allowables available in 2015, create a new environment for patients served by CMS, who will now have access to this advanced technology.
Thousands of patients worldwide have been fit with i-limb digits, providing patients with partial hand loss the ability to regain significant function and ability to complete activities in their daily lives.
“We are pleased that patients covered by CMS will now have access to the i-limb digits technology, to help empower them with a solution to support their return to function and independence,” said Ian Stevens, CEO, Touch Bionics. “Touch Bionics has a dedicated team of reimbursement specialists in our US headquarters who are equipped to assist customers with the reimbursement process from start to finish.”
About Touch Bionics
Touch Bionics is a provider of world-leading prosthetic technologies designed to achieve positive outcomes for people with upper limb deficiencies. Touch Bionics was the first company to develop an electrically powered prosthetic hand with five independently powered fingers and the company continues to be a pioneer in upper limb prosthetic solutions. The company's products include electronic prosthetic hand and prosthetic finger solutions, as well as passive silicone prostheses that closely match the natural appearance of the wearer.
A spin-out from the UK’s National Health Service, Touch Bionics was founded by inventor David Gow and is funded and supported by Archangel Informal Investment and Scottish Enterprise.